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Inhibition of Cellular Antioxidants:
A Possible Mechanism of Toxic Cell Injury
by Charles D. Puglia* and Saul R. Powell*
Cells that utilize molecular oxygen generate highly reactive oxygen-derived free radicals. Endogenous
cellular oxidants inactivate oxidant free radicals andprotect aerobic cells from oxidant injury. Glutathione,
glutathione reductase, and superoxide dismutase are key components of this antioxidant defense.
Inhibition ofantioxidant components would be expected to result in cell injury. Using exposure to oxygen
at high pressure to increase the level of oxidant free radicals, evidence is presented to support the
hypothesis that inhibition ofcellular antioxidants renders organisms more susceptible to oxygen toxicity.
Diethyldithiocarbamate at doses of 250, 500 and 1000 mg/kg inhibited rat brain superoxide dismutase
activity and shortened onset time to seizures in a dose-related manner in 4 ATA oxygen. Carmustine at
doses of 12.5, 25 and 50 mg/kg inhibits glutathione reductase activity in rat brain in proportion to the dose.
Time to onset of seizures of rats pretreated with carmustine prior to exposure to 4 ATA oxygen was
shortened, and oxidized glutathione levels were increased in the cortex and subcortex. These data suggest
that inhibition ofantioxidant components results in organisms becoming more sensitive to oxygen toxicity.
Compounds that inhibit cellular antioxidants may produce toxic cell injury by permitting intracellular
oxidant free radicals to attack essential cell constituents.
Antioxidant Defense Mechanisms
All cells that utilize molecular oxygen (02) for meta-
bolic or respiratory purposes are at risk of being
damaged by activated oxygen and other 02 derived free
radicals. The most prevalent form of this species is
thought to be superoxide anion (02w), which is formed
when elemental 02 iS utilized as an electron acceptor
during cellular metabolism or respiration. Superoxide
anion represents the product of a one-electronreduction
of elemental 02 (1). The aerobic cell possesses many
potential sources of 02T. Enzymes that catalyze the
incorporation of molecular 02 to organic molecules,
such as xanthine oxidase, aldehyde oxidase, monoamine
oxidase, NADPH-cytochrome c reductase, NADPH-
cytochrome P450 reductase, certain hydroxylases, and
several flavoproteins generate 02T. Certain auto-oxida-
tion reactions, such as those of ubisemiquinone, cate-
chols, ferrodoxins, and hemoproteins, as well as autooxi-
dation of sulfhydryl groups may result in production of
02T (2). Certain metallic ions (e.g., ferrous ions) cata-
lyze the reduction of elemental 02 to 02T (3)
02T will react with electron acceptors in the immedi-
ate vicinity. Reactants for 02T are sulfhydryl groups
such as those located at enzyme-active sites, and
unsaturated fatty acids such as those located in mem-
brane lipids. Indiscriminate and unfocused reactions of
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this type could result in inactivation of enzymes and
damage to membranes. Maintenance of normal cell
structure and function in the presence of the constant
production of highly reactive oxidant species depends
uponthe presence ofaneffective system forinactivating
them. Most 02-utilizing cells contain a multicomponent
antioxidant defense mechanism for this purpose.
The endogenous cellular antioxidant mechanism, as
currently recognized in aerobic cells, consists of a
number of components. Superoxide dismutase (SOD)
catalyzes the dismutation of 02T to H202 and 02 In
mammalian tissues this enzyme is known to exist in two
forms: a cytosolic, Cu-Zn enzyme, and a mitochondrial
Mn enzyme (4).
In mammalian systems, SOD activity tends to be
highest in tissues that have high 02 utilization (5). In
addition, tissue SOD content has been shown to vary
with tissue po in normal air-breathing mice (6). This
suggests thatthe function ofSOD is to prevent toxic cell
damage from a normal metabolic by-product of 02.
Glutathione (GSH), asulfhydryl containingtripeptide
(y-glutamyl-cysteinylglycine), appearstoplayamultifac-
eted role as an antioxidant in this system. Glutathione
maintains the reduced state ofthe sulfhydryl groups of
anumberofsulfhydryl-dependent enzymes(7). Endoge-
nously generated hydroperoxides and other 02 interme-
diates (8) are inactivated via the enzyme GSH peroxi-
dase, which utilizes GSH as a proton donor. Because
GSH has a strongreducingpotential, it can also act as a
nonspecific, nonenzymatic scavenger of free radicals
produced by 02 (9). Whether GSH interacts withPUGLIA AND POWELL
oxidants enzymatically or nonenzymatically, the by-
product is oxidized glutathione (GSSG).
The reduction of GSSG is catalyzed by the enzyme
GSH reductase utilizing NADPH as an electron donor.
NADPH is supplied by the enzyme glucose-6-phosphate
dehydrogenase (G-6-PDH). Like SOD, GSH levels tend
to be highest in those tissues with the highest utiliza-
tion of 02 (7)
Adequate levels of GSH reductase and NADPH are
critical to the maintenance ofGSH in the reduced state
which is necessary for the defense of the cell against
attack by oxidant free radicals (10). Increased G-6-PDH
activity has been demonstrated in the lungs of rats
exposed to hyperoxic gaseous environments (11).
Other components ofthe cellular antioxidant defense
system are tocopherol (vitamin E) and ascorbate
(vitamin C). Tocopherol can act as a lipid antioxidant
(2). Ascorbate appears to be able to reduce the tocoph-
erol free radical that is formed when tocopherol reduces
an oxidant substance. This interaction may explain, in
part, the synergistic antioxidant effect of tocopherol
and ascorbate in suppressing lipid peroxidation in an in
vitro system (12). The intracellular antioxidant defense
system whose components have been described above,
has evolved to prevent toxic cellinjury from oxidantfree
radicals produced during normal metabolic and respira-
tory processes.
Cellular Oxidant Damage
Much of the evidence indicating that oxidant species
can adversely affect cellular constituents has been
obtained by exposure of animals to environments con-
taining elevated levels of oxidant substances. Inspira-
tion of 02 at increased partial pressures has been
demonstrated to produce toxicity in both man and
experimental animals. This toxicity occurs as a result of
the increased production of oxidant free radicals (e.g.,
02T, hydroxyl radicals and peroxides) secondary to the
increased intracellular 02 tension. For certain enzy-
matic reactions, the production of 02- increases as the
partial pressure of02 increases (13). Oxygen toxicity in
intact animals is demonstrated most frequently as
effects on the lung and central nervous system.
According to the theory of intracellular antioxidant
defenses, the intracellular concentration ofoxidant free
radicals occurring as a result of exposure to hyperoxia
exceeds the capacity ofthe antioxidant defense mecha-
nisms to inactivate and detoxify these reactive species.
Evidence in support ofthis proposed sequence ofevents
is provided by the characteristic lag or onset time
observed between the initiation of the exposure of the
animal to the hyperoxic environment and the appear-
ance of the manifestations of toxicity (14). The time to
onset of gross toxicity is inversely related to the
pressure of 02 to which the animal is exposed (i.e., the
higher the 02 dose, the shorter the time to onset). This
relationship has been observed in the manifestations of
02 toxicity in whole animals (14), as well as in the toxic
Table 1. Effect of carmustine (25 mg/kg, IV) and exposure to
4 ATA 100% oxygen for 1 hr on oxidized glutathione (GSSG)
content of different regions of the rat brain.
Oxidized glutathione content,
nmole/g proteina
Vehicle Carmustine
Brain region control treated Change, %
Cerebral cortex 103 ± 12 143 ± 8* + 39.3
Brainstem 111 ± 18 114 ± 17 + 1.1
Cerebellum 105 ± 10 99 ± 11 - 5.6
Subcortical 89 ± 11 128 ± llt + 44.8
aValues are means ± SE of six determinations.
*p < 0.02 when compared with vehicle controls.
tp < 0.05 when compared with vehicle controls.
Table 2. Effect of carmustine (25 mg/kg, IV) and exposure to 4
ATA 100% oxygen for 1 hr on the GSH/GSSG ratio in
different regions of the rat brain.
Ratio of oxidized to reduced
glutathionea
Vehicle Carmustine
Brain region control treated Change, %
Cerebral cortex 151 t 13 95 t 7* - 36.9
Brainstem 114 t 19 107 t 3 - 6.0
Cerebellum 132 t 13 146 t 12 + 10.0
Subcortical 161 t 25 101 t 9t - 37.1
aValues are means t SE of six determinations.
*p < 0.01 when compared with vehicle controls.
tp < 0.05 when compared with vehicle controls.
effects of 02 on isolated tissues (15) and cells in culture
(16). The time required for the toxic effects of 02 to
occur as a function ofoxygen pressure can be interpre-
ted as an indication ofthe antioxidant defense capacity
ofa particular tissue or cell. From this view, the time to
onset of toxic effect would represent the time required
for that quantity of 02 to overcome the antioxidant
capacity ofthe cell and begin to attack cellular constitu-
ents which then give rise to the toxic effect.
Auto-oxidation of both nonprotein (17) and protein
sulfhydryls (18) by reactive 02 intermediates with
subsequent loss ofenzyme activity has been postulated
as a key mechanism of02 toxicity. Exposure of animals
to high pressure 02 inhibits sulfhydryl dependent
enzymes, in vivo, e.g., glutamate decarboxylase (19,20)
and lactate dehydrogenase (21). Exposure of tissue
preparations to high 02 tensions results in inhibition of
many enzymes thought to be sulfhydryl-dependent,
e.g., succinic dehydrogenase (22), Na+,K+-ATPase
(15,23). An important aspect of the interaction of
sulfhydryls with toxic 02 intermediates is that GSH
cannot only prevent 02 inactivation of certain enzymes
by being preferentially oxidized but can also reactivate
02 inactivated enzymes (22). Both of these protective
and/or restorative functions of GSH depend upon the
maintenance of GSH in the reduced form by GSH
reductase and the NADPH provided by G-6-PDH.
Interaction of the 02- or other reduction products of
02 with unsaturated tissue fatty acids may result in the
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formation of lipid free radicals (24). In the presence of
02, the lipid free radical can undergo auto-oxidation to a
lipid peroxide. The lipid peroxide thus formed can react
with other unsaturated lipids to generate a lipid
hydroperoxide and the regeneration of another oxidant
lipid radical. This results in a cyclical reaction and
the continuous reformation of lipid peroxides (11,25).
The significance of lipid peroxidation is twofold; first,
progressive lipid peroxidation may result in loss of
cellular membrane integrity; second-at least in vitro
-inactivation of enzymes by lipid peroxides has been
demonstrated, and thus loss of enzyme function may
occur (26).
The rate of oxidation ofthese cellular constituents is
dependent upon the level of 02 available to provide
oxidant free radicals and the quantity and level of
activity of the antioxidant defense components which
must first be exhausted.
Impairment of Endogenous
Antioxidants
Evidence that impaired antioxidant defense mecha-
nisms could result in adverse effects on cell function is
exemplified by the clinical syndrome associated with
G-6-PDH deficiency. Patients having erythocytes defi-
cient in this enzyme exhibit decreased red blood cell
survival time and increased sensitivity to drugs which
present the red cell with an increased level of oxidants
(27). The nature ofthe cell damage indicates a primary
target to be the lipids of the red cell membrane (27).
Experimentally, impairment ofthe endogenous antioxi-
dants has been attempted by using two methods: (1)
directly by pharmacologic manipulation of one or more
of the endogenous antioxidants or (2) indirectly by
affecting the nutritional status of the experimental
animal resulting in a deficiency of an antioxidant
constituent. Experimental nutritional deficiency in rats
has been shown to affect susceptibility to 02 toxicity.
Rats maintained on a cysteine-deficient diet develop
pathologic changes indicative of pulmonary 02 toxicity
earlier and have a decreased survival time when ex-
posed to 98% 02 at 1 ATA (atmospheres absolute). Addi-
tion of 3% cysteine to their diet reversed both effects.
Presumably, this effect was due to a deficiency of lung
GSH. Exposure of cysteine-supplemented rats to 97%
02 for 60 hr resulted in a significant increase in lung
GSH content when compared to the cysteine-deprived
rats similarly exposed (28).
Dietary deprivation of selenium renders rats more
susceptible to 02 pulmonary damage. This effect was
associated with a decrease in lung GSH-peroxidase
activity (29).
Exposure of tocopherol-deficient mice to 45 psia
(pounds per square inch absolute) 02 for 1 hrresults in a
higher incidence of seizures. In these studies, tocoph-
erol deficiency is associated with increases in brain
content of peroxide and lipid peroxides following 02.
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FIGURE 1. Effect of diethyldithiocarbamic acid (DDC) on time to
seizure of rats exposed to 4 ATA 100% oxygen. Two hours after
treatment with DDC or vehicle (saline) the rats were exposed to 4
ATA 100% oxygen until seizure. Values are expressed as the mean
± SE percent ofcontrol. The control mean ± SE time to seizures
were 138 + 15, 156 - 8 and 136 ± 15 min at the 250, 500 and 1000
mg/kg DDC points, respectively. The number ofrats in each group
was six to eight. *p < 0.01 as determined by one-way ANOVA.
exposure. As with the cysteine-deprived rats, these
effects were reversible upon addition of tocopherol to
the diet (30,31).
Pharmacological manipulation ofthe endogenous anti-
oxidants has been attempted using several agents.
Diethyldithiocarbamic acid (DDC) is an inhibitor ofthe
Cu-Zn SOD (32). Treatment ofrats with this compound
has been demonstrated to potentiate pulmonary dam-
age in rats exposed to 95% 02 at 1 ATA (33) and to
decrease survival time of rats exposed to 95% 02 at 1
ATA (33) or 2 ATA 100% 02 (34).
In our laboratory, experiments with DDC have been
conducted to ascertain the relationship of central ner-
vous system SOD inhibition in brain on the rate of
development ofCNS 02 toxicity. TIeatment ofrats with
DDC at doses of250, 500 and 1000 mg/kg, IP, results in
a dose-dependent decrease in time to seizure in rats
exposed to 4 ATA 100% 02. The effect on time to seizure
was in the presence of a dose-dependent decrease in
brain Cu-Zn SOD activity (35).
This laboratory has also been examining the effect of
inhibition of GSH reductase on rate of development of
CNS 02 toxicity. 1,3-Bis(2-chloroethyl)-1-nitrosourea or
carmustinewasfirstdemonstrated toproduce ageneral-
ized inhibition of GSH reductase by Frischer and
Ahmad (36). Treatment of rats with carmustine intra-
venously, at doses of 12.5, 25 and 50 mg/kg, produces a
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FIGURE 2. Effect of diethyldithiocarbamic acid (DDC) on rat brain
superoxide dismutase (SOD) activity. Two hours after treatment
with DDC or vehicle (saline) whole brain SOD activity was
determined. Values are expressed as mean ± SE percent of
control. Mean ± SE control SOD activities were 11.2 ± 0.5, 12.5
0.7 and 8.1 ± 0.4 units/mg protein at the 250, 500 and 1000 mg/kg
DDC points, respectively The number of rats in each group was
seven to eight. *p < 0.05 as determined by one-way ANOVA.
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FIGURE 3. Effect ofcarmustine on time to seizure ofrats exposed to
4 ATA 100% oxygen. One hour after treatment with carmustine or
vehicle (50% ethanol/saline) the rats were exposed to 4 ATA 100%
oxygen until seizure. Values are expressed as the mean ± SE
percent change from control. The pooled control mean ± SE time
to seizure was 137 ± 8 min. The number ofrats in each group was
six to eight. *p < 0.001 as determined by one-way ANOVA.
dose-dependent decrease in time to seizure at 4 ATA
100% 02. These doses of carmustine also resulted in a
dose-dependent inhibition of brain GSH reductase
activity. Furthermore, the decreased time of onset of
seizures was associated with increased GSSG content of
the cortex and subcortex. This suggests that inhibition
of brain GSH reductase in the presence of an oxidizing
environment alters the GSH status of neuronal tissue
and thus increases the sensitivity of this tissue to the
toxic effects of 02 (37).
In all the experiments cited above, evidence oftissue
damage was demonstrated in an environment which
exposed cells to significantly elevated levels of 02. The
cellular antioxidant defenses normally function to pro-
tect cellular constituents from endogenously derived
oxidant free radicals generated in cells exposed to 0.2
ATA 02 in sea level air. Inhibition of antioxidant
components would be expected to result in 02-mediated
cellinjury even in normoxic environments. Accordingto
the 02 dose-toxic response relationship the rate of
development of oxidant toxic cell injury would be
dependent upon the extent as well as the duration of
antioxidant inhibition, since 02 dose would remain
constant. Based on the existing onset times for the
various manifestations of 02 toxicity, measurable nor-
moxic 02 toxicity may be expected to require days or
perhaps weeks to occur. The ability of exogenous
substances to impair cellular antioxidants may repre-
sent a significant mechanism of toxic cell injury by
endogenously generated oxidant species.
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FIGURE 4. Effect of carmustine on rat brain glutathione reductase
activity. One hourafter treatmentwith carmustine orvehicle (50%
ethanol/saline) whole rat brain glutathione reductase activity was
determined. Values are expressed as mean ± SE percent change
from control. The control mean ± SE values of glutathione
reductasewere (O)8.2± 0.3, (0)5.0 ± 0.1 and (A)4.8 ± 0.3units.
The number of rats in each group was six to eight. *p < 0.001 as
determined by one-way ANOVA.
310INHIBITION OF ENDOGENOUS ANTIOXIDANTS 311
This work was supported by research grant R01 HL24454 from the
National Institutes of Health.
The authors wish to thank Bristol Labs. Inc. and the National
Cancer Institute for graciously supplying the carmustine used in
these experiments. The technical assistance of Ms. Donna McDonald
and Ms. Margaret Eichman contributed greatly to the data reported
here.
REFERENCES
1. Fee, J. A., and Valentine, J. S. Chemical and physical properties
of superoxide anion. In: Superoxide and Superoxide Dismutases
(A. M. Michelson, J. M. McCord and I. Fridovich, Eds.),
Academic Press, New York, 1977, pp. 19-60.
2. Fisher, A. B., Bassett, D. J. P., and Forman, H. J. Oxygen
toxicity ofthe lung: biochemical aspects. In: Pulmonary Edema.
American Physiological Society, Bethesda, 1979, pp. 207-216.
3. Weiss, J. J. The auto-oxidation offerrous ions in aqueous solution.
Experientia 9: 61-62 (1953).
4. McCord, J. M., and Fridovich, I. Superoxide dismutases: a
history. In: Superoxide and Superoxide Dismutases (A. M.
Michelson, J. M. McCord and I. Fridovich, Eds.), Academic
Press, New York, 1977, pp. 1-10.
5. Matkovics, B. Effects of plant and animal lesions on superoxide
dismutase activities. In: Superoxide and Superoxide Dismutases
(A. M. Michelson, J. M. McCord, and I. Fridovich, Eds.),
Academic Press, New York, 1977, pp. 501-517.
6. Liu, J., Simon, L. M., Phillips, J. R., and Robin, E. D.
Superoxide dismutase (SOD) activity in hypoxic mammalian
systems. J. Appl. Physiol. 42: 107-110 (1977).
7. Jocelyn, P C. Thiols and disulfides in animaltissues. In: Biochem-
istry of the SH Group, Academic Press, New York, 1972, pp.
261-278.
8. Chance, B., Boveris, A., Nakase, Y, and Sies, H. Hydroperoxide
metabolism: an overview. In: Functions of glutathione in Liver
and Kidney (H. Sies and A. Wendel, Eds.), Springer-Verlag, New
York, 1978, pp. 95-106.
9. Barron, E. S. G. Oxidation of some oxidation-reduction systems
by oxygen at high pressures. Arch. Biochem. Biophys. 59:
502-510 (1955).
10. Haugaard, N. The effects of high and low oxygen tensions on
metabolism. In: Molecular Oxygen in Biology: Topics in Molecular
Oxygen Research (O. Hayaishi, Ed.), North-Holland Publishing
Co., 1974, pp. 163-182.
11. Tierney, D., Ayers, L., Herzog, S., and Yang, L. Pentose
pathwayandproductionofreducednicotinamide adenine dinucleo-
tide phosphate, a mechanism that may protect lungs from
oxidants. Am. Rev. Respir. Dis. 108: 1348-1351 (1973).
12. Leung, H., Vang, M. J., and Mavis, R. D. The cooperative
interaction between vitamin E and vitamin C in suppression of
peroxidation of membrane phospholipids. Biochem. Biophys.
Acta 664: 266-272 (1981).
13. Fridovich, I., and Handler, P Xanthine oxidase V Differential
inhibition of the reduction of various electron acceptors. J. Biol.
Chem. 237: 916-921 (1962).
14. Clark, J. M., and Lambertsen, C. J. Pulmonary oxygen toxicity:
a review. Pharmacol. Rev. 23: 37-133 (1971).
15. Kovachich, G. B., Mishra, 0. P, and Clark, J. M. Depression of
cortical Na+-K+-ATPase activity in rats exposed to hyperbaric
oxygen. Brain Res. 206: 229-232 (1981).
16. Gendimenico, G. J. A correlation between the toxic effects of
hyperbaric oxygen on cell viability and uracil nucleotide metabo-
lism in cultured rat neuroblastoma cells. Ph.D. Dissertation,
Univ. of Pennsylvania, 1983.
17. Michaelis, L., and Barron, E. S. G. Oxidation-reduction systems
of biological significance, II reducing effect of cysteine by free
metals. J. Biol. Chem. 81: 29-40 (1929).
18. Tijoe, G., and Haugaard, N. Oxygen inhibition of crystalline
glyceraldehyde phosphate dehydrogenase and disappearance of
enzyme sulfhydryl groups. Life Sci. 11: 329-335 (1972).
19. Wood, J. D., and Watson, W J. The effect of hyperoxia and
hypoxia on free and bound gamma-aminobutyric acid in mamma-
lian brain. Can. J. Biochem. 47: 994-997 (1969).;
20. Tunnicliff, G., and Wood, J. D. The inhibition of mouse brain
neurotransmitter enzymes by mercury compounds and a compari-
sonwiththeeffects ofhyperbaric oxygen. Comp. Gen. Pharmacol.
4: 101-105 (1973).
21. Banister, E. W, Davison, A. J., Bhaktan, N. M. G., and
Asmundson, C. Biochemical effects ofoxygen at high pressure in
rats. Can. J. Phys. Pharmacol. 51: 673-678 (1973).
22. Stadie, W C., and Haugaard, N. The effect of high oxygen
pressure upon enzymes: succinic dehydrogenase and cytochrome
oxidase. J. Biol. Chem. 161: 153-174 (1945).
23. Ubels, J. L., and Hoffert, J. R. Cellular oxygen toxicity: the
effect of hyperbaric oxygen on retinal Na+-K+--ATPase. Exp.
Eye Res. 32: 77-84 (1981).
24. Kellog, E. W, and Fridovich, I. Superoxide, hydrogen peroxide,
and singlet oxygen in lipid peroxidation by xanthine oxidase
system. J. Biol. Chem. 250: 8812-8817 (1975).
25. Recknagel, R. O., and Glende, E. A. Lipid peroxidation: a
specific form of cellular injury. In: Handbook of Physiology
-Reactions to Environmental Agents (D. H. K. Lee, Ed.),
American Physiological Society, Bethesda, 1977, pp. 91-601.
26. Green, R., Little, C., and O'Brien, P J. The inactivation of
isocitrate dehydrogenase by a lipid peroxide. Arch. Biochem.
Biophys. 142: 598-605 (1971).
27. Kellermeyer, R. W Drugs and G-6-PD deficiency of red cells. In:
Drugs and Hematologic Reactions (N. V Dimitrov and J. H.
Nodine, Eds.), Grune and Stratton, NewYork, 1974, pp. 109-122.
28. Deneke, S. M., Gershoff, S. N., and Fanburg, B. L. Potentiation
of oxygen toxicity in rats by dietary protein or amino acid
deficiency J. App. Physiol. 42: 107-110 (1977).
29. Cross, C. E., Hasegawa, G., Reddy, K. A., and Omaye, S. T.
Enhanced lung toxicity of 02 in selenium-deficient rats. Res.
Commun. Chem. Pathol. Pharmacol. 16: 695-706 (1977).
30. Zirkle, L. G., Mengel, C. E., Horton, B. O., and Duffy, E. J.
Studies of oxygen toxicity in the central nervous system. Aero-
space Med. 36: 1027-1032 (1965).
31. Jerrett, S. A., Jefferson, D., and Mengel, C. E. Seizures, H202
formation and lipid peroxides in brain during exposure to oxygen
under high pressure. Aerospace Med. 44: 40-44 (1973).
32. Heikkila, R. E., Cabbat, F S., and Cohen, G. In vivo inhibition of
superoxide dismutase in mice by diethyldithiocarbamate. J. Biol.
Chem. 28: 2182-2185 (1976).
33. Deneke, S. M., and Fanburg, B. L. Involvement of glutathione
enzymes in oxygen tolerance development by diethyldithio-
carbamate. Biochem. Pharmacol. 29: 1367-1373 (1980).
34. Forman, H. J., York, J. L., and Fisher, A. B. Mechanism for the
potentiation of oxygen toxicity by disulfiram. J. Pharmacol.
Exptl. Therap. 212: 452-455 (1980).
35. Loeb, G. A., and Puglia, C. D. Effect of superoxide dismutase
inhibition by diethyldithiocarbamate on time to seizure in oxygen
at 4 ATA. Fed. Proc. 41: 1620 (1982).
36. Frischer, H., and Ahmad, T. Severe generalized glutathione
reductase deficiency after anti-tumor chemotherapy with BCNU
(1,3-bis-(chloroethyl)-1-nitrosourea). J. Lab. Clin. Med. 89:
1080-1091 (1977).
37. Powell, S. R., and Puglia, C. D. The role of brain glutathione in
potentiation of CNS oxygen toxicity by carmustine. Fed. Proc.
42: 660 (1983).